Cargando…

Elevated serum FGF21 predicts the major adverse cardiovascular events in STEMI patients after emergency percutaneous coronary intervention

BACKGROUND: Although there have been several studies related to serum fibroblast growth factor 21 (FGF21) levels and acute myocardial infarction, the value of serum FGF21 levels in ST-segment elevation myocardial infarction (STEMI) patients after emergency percutaneous coronary intervention (PCI) ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Lingyun, Jiang, Wenlong, Qian, Huidong, Zheng, Ruolong, Li, Weizhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2021
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487623/ https://www.ncbi.nlm.nih.gov/pubmed/34703671 http://dx.doi.org/10.7717/peerj.12235

Ejemplares similares

Elevated serum FGF21 levels predict heart failure during hospitalization of STEMI patients after emergency percutaneous coronary intervention
por: Gu, Lingyun, et al.
Publicado: (2023)

Recurrent ST-Elevation Myocardial Infarction (STEMI) in Coronary Artery Aneurysm Secondary to Atherosclerosis
por: Bhuiyan, Md, et al.
Publicado: (2022)

Major Adverse Cardiovascular Events: An Inevitable Outcome of ST-elevation myocardial infarction? A Literature Review
por: Poudel, Ishan, et al.
Publicado: (2019)

Co-relation of Monocyte Count in High vs. Low Thrombus Burden ST-Segment Elevated Myocardial Infarction (STEMI) Patients Undergoing Primary Percutaneous Coronary Intervention
por: Zeeshan, Muhammad, et al.
Publicado: (2022)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Not All ST Elevation Is STEMI: Brugada Phenocopy Induced by Hyperkalemia
por: Greffie, Ermias S, et al.
Publicado: (2023)

Effect of the index of cardiac electrophysiological balance on major adverse cardiovascular events in patients with diabetes complicated with coronary heart disease
por: Lin, Yuan, et al.
Publicado: (2023)

COVID-19 Pneumonia: ST-segment Elevation Myocardial Infarction (STEMI) and Myocarditis
por: Ali, Azhar, et al.
Publicado: (2020)

Successful Percutaneous Balloon Angioplasty in a Patient Presenting With STEMI and Acute Intracranial Hemorrhage
por: Obagi, Aref, et al.
Publicado: (2021)

Adverse Events in Primary Percutaneous Coronary Angioplasty With Drug-Eluting Stents Compared With Drug-Coated Balloons: A Retrospective Outlook
por: Sharif Khan, Hamid, et al.
Publicado: (2020)

In-Hospital Outcomes of Coronary Artery Stenting in Patients With ST-Elevation Myocardial Infarction (STEMI) and Metabolic Syndrome: Insights From the National Inpatient Sample
por: Igbinosa, Owen, et al.
Publicado: (2022)

Prolonged Use of Tirofiban Infusion Without Percutaneous Coronary Intervention To Achieve Optimal Results in a COVID-19 Positive Patient With Inferior ST Segment Elevated Myocardial Infarction (STEMI) Secondary to Thromboembolism: A Case Report
por: Khan, Zahid, et al.
Publicado: (2022)

Trial Sequential Analysis Comparing Bleeding and Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation and Acute Coronary Syndrome on Dual versus Triple Therapy
por: Munir, Muhamad B, et al.
Publicado: (2019)

Extensive Coronary Thrombosis as a Sequelae of COVID-19 Presenting as a STEMI
por: Madkour, Muhammad, et al.
Publicado: (2021)

Shark Fin Electrocardiogram: A Deadly Electrocardiogram Pattern in ST-Elevation Myocardial Infarction (STEMI)
por: Jaiswal, Amit K, et al.
Publicado: (2021)

Clinical Features of the Aslanger Pattern to Compensate for the Limitation of ST-Elevation Myocardial Infarction (STEMI) Criteria
por: Miyauchi, Eiji, et al.
Publicado: (2023)

Risk factors for major adverse cardiovascular events after the first acute coronary syndrome
por: Okkonen, Marjo, et al.
Publicado: (2021)

Early Major Adverse Cardiovascular Event in a Patient With Chronic Kidney Disease: A Case Report
por: Saleh Juman Alseiari, Saleh, et al.
Publicado: (2023)

Eptifibatide-Induced Severe Thrombocytopenia After ST-Elevation Myocardial Infarction (STEMI): A Case Report
por: Gheith, Zaid, et al.
Publicado: (2022)

Acquired Hemophilia A and ST-Elevation Myocardial Infarction (STEMI): A Rare Presentation and Management Dilemma
por: Yabut, Jevin, et al.
Publicado: (2023)

An Unusual Case of ST-Elevation Myocardial Infarction (STEMI) Mimicker: Pneumopericardium Secondary to Gastro-Pericardial Fistula
por: Ahmed, Asmaa, et al.
Publicado: (2023)

Olmesartan Attenuates the Impairment of Endothelial Cells Induced by Oxidized Low Density Lipoprotein through Downregulating Expression of LOX-1
por: Zhang, Hua, et al.
Publicado: (2012)

Left Ventricular Ejection Fraction along with Zwolle Risk Score for Risk Stratification to Enhance Safe and Early Discharge in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: A Retrospective Observational Study
por: Banga, Sandeep, et al.
Publicado: (2019)

Predictors of short-term outcomes in patients undergoing percutaneous coronary intervention in cardiogenic shock complicating STEMI—A tertiary care center experience
por: Raja, Deep Chandh, et al.
Publicado: (2018)

MACE in the Race: A Canadian Perspective on Major Adverse Cardiac Events (MACE) During Running
por: Abrahim, Mohammed
Publicado: (2022)

Impact of Primary Percutaneous Coronary Intervention on Complete Atrioventricular Block With Acute Inferior ST-Elevation Myocardial Infarction
por: Malik, Jahanzeb, et al.
Publicado: (2020)

Cytochrome P450 2C19 Polymorphisms and Its Association With Major Adverse Cardiac Events in Post-coronary Intervention Patients on Clopidogrel in the Tertiary Care Center
por: Kambhampati, Nikhil Teja, et al.
Publicado: (2023)

Prediabetes as a risk factor for major adverse cardiovascular events
por: Mando, Ramy, et al.
Publicado: (2021)

Ongoing COVID-19 Pandemic Effects on Admissions and In-Hospital Outcomes in Patients With ST-Elevation Myocardial Infarction (STEMI): An Albanian Observational Study
por: Simoni, Leonard, et al.
Publicado: (2022)

Predicting 30-Day Mortality Using ST-Segment Elevation Resolution in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: An Indian Scenario
por: Mandal, Shankar Chandra, et al.
Publicado: (2023)

All-Cause Mortality and Incidence of Major Adverse Cardiac Events in Sickle Cell Nephropathy: A Comparative Study
por: Udani, Kunjan, et al.
Publicado: (2021)

Elevated Baseline Serum Fibrinogen: Effect on 2‐Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention
por: Ang, Lawrence, et al.
Publicado: (2017)

Assessment of the Efficacy and Safety of Early Intracoronary Nicorandil Administration in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Gupta, Himanshu, et al.
Publicado: (2022)

STEMI Secondary to Coronary Vasospasm: Possible Adverse Event of Methylphenidate in a 21-Year-Old Man with ADHD
por: Baumeister, Timo-Benjamin, et al.
Publicado: (2016)

Lack of prognostic significance for major adverse cardiac events of soluble suppression of tumorigenicity 2 levels in patients with ST-segment elevation myocardial infarction
por: Kim, Min, et al.
Publicado: (2021)

Diurnal Variation in Outcomes of Percutaneous Coronary Intervention
por: Malik, Jahanzeb, et al.
Publicado: (2020)

Predictive value of three Inflammation-based Glasgow Prognostic Scores for major cardiovascular adverse events in patients with acute myocardial infarction during hospitalization: a retrospective study
por: Zhu, Houyong, et al.
Publicado: (2020)

Multicenter analysis to assess risk of major adverse cardiac events in patients undergoing high‐sensitivity troponin testing in the emergency department
por: Serven, Victoria, et al.
Publicado: (2023)

A Case Of Awake Percutaneous Extracorporeal Membrane Oxygenation For High-risk Percutaneous Coronary Intervention
por: Liu, Shuangbo, et al.
Publicado: (2017)

Inadvertent Septal Ablation During Percutaneous Coronary Intervention
por: Gao, Feng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bclqgl3k1o513kaqkbt48ftfqa